Skip to main content
. 2015 Dec 28;12:S1–S110. doi: 10.1111/j.1470-9465.2006.12_4_1426.x

Table.

List of proposed antibiotic* prescribiitg quality indicators

  • 1: Consumption of antibacterials for systemic use (J01) expressed in DDD per 1000 inhabitants per day

  • 2: Consumption oftetracyclines (J01 A) expressed in DDD per 1000 inhabitants per day

  • 3: Consumption of penicillins (J01C) expressed in DDD per 1000 inhabitants per day

  • 4: Consumption of cephalosponns (JOID) expressed in DDD per 1000 inhabitants per day

  • 5: Consumption of sulfonamides and trimethoprim (J01E) expressed in DDD per 1000 inhabitants per day

  • 6: Consumption of MLS, i.e. macrolides, line osamides and streptogramins (J01F) expressed in DDD per 1000 inhabitants per day

  • 7: Consumption of quinolones (J01M) expressed in DDD per 1000 inhabitants per day

  • 8: Consumption of tetracycline (J01 A) expressed as percentage of the total antibiotic consumption**

  • 9: Consumption of penicillins (JO 1C) expressed as percentage of the total antibiotic consumption**

  • 10: Consumption of cephalosporins (J01D) expressed as percentage of the total antibiotic consumption**

  • 11: Consumption of sulfonamides and trimethoprim (J DIE) expressed as percentage of the total antibiotic consumption**

  • 12: Consumption of MLS, i.e. macrolides, lineosamides andstreptogramins (J01F] expressed as percentage of the total antibiotic consumption**

  • 13: Consumption of quinolones (J01M) expressed as percentage of the total antibiotic consumption**

  • 14: Consumption of β-lactamase sensitive penicillins (J01CE) expressed as percentage of the total antibiotic consumption**

  • 15: Consumption of combinations of penicillins, including β-lactamase inhibitor (J01CR) expressed as percentage of the total antibiotic consumption**

  • 16: Consumption of 3rd and 4th generation of cephalosporins {J01 (PD+DE)} expressed as percentage of the total antibiotic consumption**

  • 17: Ratio of the consumption of narrow spectrum {J01 (CE+DB+FA01)} to the consumption of broad spectrum penicillins, cephalosporins and macrolides {J01 (CR+DC+DD+(F-FA01))}

  • 18: Consumption of fluoroquinolones (J01M A) expressed as percentage of the total antibiotic consumption**

  • 19: Seasonal variation of the total antibiotic c onsumption**

  • 20: Seasonal variation of quinolone consumption(J01M)

  • 21: Index of seasonal variation of quinolone consumption (JO1M) takinginto account their use in DDD per 1000 inhabitants per day

  • 22: Index of longitudinal trends of antibiotic consumption

Structural indicators
  • 23: Diversity of the therapeutic arsenal of antibacterials for systemic use

  • 24: Number of items re corded in the national register of available antibacterials for systemic use

*

Antibiotics are describedusing the WHO ATC classification (version2004).

**

Total antibiotic consumption means the consumption of antimicrobials for systemic use (JO1)